This information was published on 2025-11-05T17:13:51 for IP Right Acceptance Published.
| Field | Value |
| (210) | 2564791 (IR 1864023) |
| (220) |
28 May 2025
|
| (300) |
US, 20 Dec 2024, 98915324
|
| (511) (510) |
Class 5
Gene therapy products, namely, genetically engineered tissues for transplant purposes; pharmaceutical preparations for adeno-associated virus delivery to control gene expression and gene replacement; pharmaceutical preparations for adeno-associated virus to deliver corrective genes, replace defective genes or delivery therapeutic genes. |
| (540) | ASYMPTOTE GENETIC MEDICINES |
| (550) | Word |
| (730) |
Asymptote Genetic Medicines, Inc.
|
Find out more about publications on the About page.